BioSpace News Archive

ERYTECH Pharma (Nasdaq & Euronext: ERYP),a clinical-stage biopharmaceutical company, leader in red blood-cell based cancer therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted eryaspase Fast Track designation for the treatment of acute lymphocytic leukemia (ALL)patients who have developed hypersensitivity reactions to E. coli-derived pegylated asparaginase (PEG-ASNase).

Kura Oncology, Inc., a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, announced that it will report second quarter 2021 financial results after the close of U.S. financial markets on Thursday, August 5, 2021.

Zynex, Inc., an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, reported financial results for its second quarter ended June 30, 2021.

CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced its financial results for the second quarter ended June 30, 2021.

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will release its second quarter 2021 financial results and provide a corporate update on Thursday, August 5, 2021, after the close of the U.S. financial markets.

DURECT CorporationDURECT Corporation announced financial results for the three months ended June 30, 2021 and provided a corporate update.

AngioDynamics, Inc., a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the 41st Annual Canaccord Genuity Virtual Growth Conference at 9:00 a.m. ET on Wednesday, August 11, 2021.

CooperCompanies, announced it will release third quarter 2021 financial results on Thursday, September 2, 2021, at 4:15 PM ET.

Vertex Pharmaceuticals Incorporated reported consolidated financial results for the second quarter ended June 30, 2021 and raised full-year 2021 guidance for product revenues to $7.2 to $7.4B.

SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, August 5th, 2021.